Pelthos Therapeutics PTHS
NYSE PTHS
$20.77 +0.11 (+0.53%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pelthos Therapeutics (PTHS) Revenue (2025 - 2026)

Updated

Pelthos Therapeutics (PTHS) posted Revenue of $15.6 million for Q2 2026, up 43.1% from the prior quarter.

Analysis

Pelthos Therapeutics (PTHS) Revenue (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Revenue at Pelthos Therapeutics was $43.3 million; for FY2025, it was $16.8 million.

  • According to Business Quant data, Revenue for the three prior quarters was $10.91 million (Q1 2026), $9.39 million (Q4 2025) and $7.41 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.31 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 16.99 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 15.38 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 7.80 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 15.03 Bn
10 Pelthos Therapeutics 77.24 Mn -11.16 Mn 11.99 Mn 15.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.60 Mn
Mar 31, 2026 10.91 Mn
Dec 31, 2025 9.39 Mn
Sep 30, 2025 7.41 Mn
API Access

Pelthos Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=PTHS&period=max&api_key=YOUR_API_KEY